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The identification of the vasopressor substance responsible for the elevation 
of  the  blood pressure  in  renal  hypertension  would  be a  contribution  to  the 
knowledge of the mechanism causing this phenomenon. One of the pressor sub- 
stances suspected of being the chemical mediator of hypertension is the poly- 
pepfide hypertensin which is produced by the enzymatic action of renin upon 
its substrate, a-2-globulin. 
Hypertensin has not yet been isolated in pure form although it has been obtained 
in a state of purity which had a prcssor potency equal to that of epinephrine (1). The 
molecular weight of hypertensin is approximately 2700. To judge from paper chroma- 
tography it  contains  the following  amino  acids:  lysine,  histidine,  glycine,  alanine, 
serine,  proline,  valine, tyrosine, leucine  (or isoleucilae), aspartic acid, and glutamic 
acid. It has a characteristic pressor effect when injected intravenously, the maximum 
rise in blood pressure occuring in 1 minute or less and returning to normal in 3 minutes 
or less. Continuous  injection produces an increase  in blood pressure which  is  main- 
tained during the entire period of injection.  The assay of hypertensin must be accom- 
plished  by biological  methods,  usually by its  effect upon blood pressure following 
intravenous injection into an intact anesthetized animal. 
The identification  of hypertensin in an unknown solution,  although never absolute, 
can be made reasonably certain by using methods for the preparation of extracts 
which are as chemically specific as possible. Further evidence can be obtained that the 
pressor material is hypertensin by use of simple inactivation tests with proteolytic 
enzymes as well as by the demonstration of its pharmacological properties. 
Although  hypertensin has been isolated from the circulating arterial blood 
of dogs with benign experimental renal hypertension by dialysis in an artificial 
kidney, it was not possible to conclude from these experiments that it was the 
vasoconstrictor substance responsible for the elevation of blood pressure (2, 3). 
As a  result of these studies, it was concluded that a direct method of isolating 
hypertensin from blood must be developed. 
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This  study  describes  a  chemical  method  for  the  isolation  of  hypertensin 
directly from blood and its biological assay. Blood samples were drawn directly 
from  the  femoral  artery  of dogs  into  95  per  cent  ethanol,  which  stopped  the 
action of the enzymes renin and hypertensinase,  and precipitated  the proteins 
of the  blood.  The hypertensin  in  the filtrate was  then  concentrated  and  suffi- 
ciently purified  for final assay  on anesthetized  rats. 
Methods 
Preparation of Extrazts.--265  gin. (250 ml.)  of whole blood was drawn directly from the 
femoral artery of unanesthetized dogs into one liter of approximately 95 per cent ethanol. The 
ethanol was contained in a 2 liter heavy duty Erlenmeyer flask in which there was maintained 
a partial vacuum. A 17-gauge needle, which was used for puncturing the femoral artery, was 
connected to the Erlenmeyer flask by a polyethylene catheter with an internal diameter of 
0.047 inches. The flask was placed on a torsion balance, tared, and measurements of the sample 
accomplished by weighing. The flask was weighed and shaken intermittently during the period 
of collection in order to obtain a rapid and thorough mixing of the blood and ethanol. 1½ to 4 
minutes was required to collect the samples of blood. (It took less than 5 seconds for the blood 
to pass from the femoral artery through the polyethylene tubing into the ethanol.) 
After the sample was collected, the blood and ethanol mixture was shaken for 5 minutes 
and then filtered through No. 42 Whatman filter paper on an 18 cm. Buchner funnel. The mat 
of the precipitate, while still unbroken and undisturbed, was washed by drawing through it 1 
liter of approximately 80 per cent ethanol (800 ml. of 95 per cent ethanol diluted to 1000 ml. 
with water). The precipitate was then discarded and 10 ml. of a solution containing 7 m. eq. 
of HCI and 2 gm. of NaC1 was added to the filtrate which was then stored in the deepfreeze 
from 1 to 14 days. 
A grayish white precipitate formed in the filtrate during its storage at -  15  ° in the deep- 
freeze. The clear supernatant filtrate was decanted and the remainder was centrifuged at high 
speed for 10 minutes at -- 15  °. The superuatant obtained by centrifuging was combined with 
that which was decanted and the precipitate discarded. The filtrate was vacuum-concentrated 
to 100 ml. at temperatures  below 20  ° with the aid of 1 ml. of anfifoam solution  (toluene 
saturated with antifoam A, Dow Coming Corp.). The pH of the solution, about 2.5, was ad- 
justed to 5.5 with 2.5 ~ NaOH in order to precipitate any of the proteins that remained in the 
filtrate. This procedure resulted in a  solution which had a  negative Biuret test for protein. 
The mixture was then centrifuged at high speed at 0 to 3* for 15 minutes and the supernatant 
decanted. The precipitate was washed by shaking with 50 ml. of 2 per cent NaC1 and recentri- 
fuged in a similar manner. The dear wash was then combined with the first superuatant and 
the pH was readjusted to 2.5 by the addition of HC1. The solution was then extracted twice 
in the ice box at 5 to 10  ° with 200 ml. of diethyl ether. 15 to 30 minutes was allowed for the 
separation of the phases and then the ether extracts were discarded. Extraction with ether 
was necessary to remove the materials which interfered with the flow of the filtrate through 
the alumina column. 
The aqueous layer was vacuum-concentrated to 10 ml. with the aid of 0.2 ml. of antifoam 
solution. This acid solution, saturated with NaC1, was then extracted twice with 25 ml. of 
n-butanol. Under these conditions, hypertensin passes quantitatively into the butanol. 
The aqueous layer obtained from the butanol extractions was highly depressor and had an 
absorption spectrum similar to that of adenylic acid. 
The hypertensin was removed from the butanol by adsorption onto a column of alumina. 
The alumina (activated 80 to 200 mesh, Fischer Scientific Co.) was prepared in the following 
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hydrochloric acid diluted 1:5 with distilled water. The hydrochloric acid was filtered off, the 
alumina was  washed thoroughly  with distilled  water (about  30 gallons)  until  the  wash  water, 
when  treated  with  silver  nitrate,  gave  only  a  faint  opalescence.  The  alumina was  then  alr-dricd 
for  48  hours.  The column  was  prepared  by  pouring  a slurry  of  12  gin.  of  alumina  and butanol 
into  a glass  tube 14  ram.  in  diameter.  The alumina column  was supported  on  a small  wisp of 
cotton  and a glass  bead placed  in  a constricted  portion  of  the tube.  The tube was tapped to 
settle the adsorbent. After the butanol extract had passed through the alumina, the column 
was washed with 200 nil. of 85 per cent ethanol which removed additional depressor materials. 
This wash was discarded. 
The hypertensin was eluted from the alumina by washing the column with 200 ml. of 50 
per cent ethanol. This solution was vacuum-concentrated and then transferred to a centrifuge 
tube with the aid of small washes of water until the final volume was 10 ml. The pH was ad- 
justed to 7.0-7.4 with 0.1 N NaOH using two drops of 0.01 per cent phenol red indicator. The 
precipitate which formed was removed by centrifuging at high speed ~t 1 to 3  ° for 15 minutes. 
The supematant was transferred to a 50 mi. conical centrifuge tube and then one drop of 0.1 
N HC1 and caprylic alcohol was added. The solution was then evaporated to dryness in this 
tube under vacuum at 40  °. The residue was redissolved in 1 ml. of distilled water and the color 
of the indicator was again made to a  faint pink by using minute amounts of 0.1 N NaOH. 
The tube was capped and centrifuged at a low speed for 5 minutes. The supernatant fluid was 
transferred to a small test tube which was stoppered and placed in the deepfreeze until assayed. 
Recovery Expsrimcnt.--The  chemical method was tested for its ability to recover hyperten- 
sin from blood by processing and assaying samples prepared in the following manner: 250 mL 
of blood was collected from each of 8 normal dogs by direct puncture of the femoral artery. 
The blood was heparinized, pooled, and then redistributed in samples of 250 ml.  0.2 unit of 
hypertensin was added to 6 of the samples. No hypertensin was added to the other 2 samples 
in order to determine the amount of pressor material present in 250 ml. of arterial blood col- 
lected in this fashion. The hypertensin was usually added to the liter of ethanol just prior to 
the addition of the 250  ml. sample of blood. It was found, however, that the addition of 
hypertensin directly to the blood 30 seconds prior to its mixture with the ethanol did not sub- 
stantially alter the amount of hypertensin recovered. 
To determine the per cent of recovery in all of the experiments, two control samples to 
which hypertensin had been added were processed in parallel with groups of 6 experimental 
samples drawn from normal or hypertensive dogs. 
Inactivation Experiments.--The effect of trypsin on the pressor activity of the extracts was 
determined by incubating approximately 1 mg. of the dialyzed enzyme (Armours crystallized) 
with 1.0 ml. of the extract for 2 hours at 39  °. Each extract was made 0.1 ~r with respect to 
sodium phosphate buffer pH 7.4. Merthiolate at a concentration of 1 to 25,000 was used as a 
preservative. The enzyme was inactivated and removed from the solution after incubation 
and before assay, by heating to 100  ° for 10 minutes followed by centrifugation. Each test was 
accompanied by its own control which consisted of the incubation of the extract in similar 
fashion with previously heat-inactivated trypsin. 
Assay Methods.--The pressor effect of the preparations was assayed by intravenous injec- 
tion into rats and compared to that produced by an injection of a standardized hypertensin 
solution. All assays are expressed in terms of Goldblatt units. A detailed description of the 
assay methods has been previously pubfished (3). 
EXPERIMENTAL 
A  pool  of extracts  representing  23  different  preparations  purified  as  above 
was found on analysis to contain 0.22 m. eq. of Na, 0.0011  m. eq. of K, 2.71 mg. 
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ml. of blood. The extraneous material present did not have a  depressor effect 
upon the blood pressure of the test animal. 
An experiment designed to test the ability of the chemical method to recover 
hypertensin added to individual samples of blood drawn from a  single pool of 
normal dog blood is shown in Table I. Five such experiments have been con- 
ducted. The recovery of added hypertensin in all five experiments, which con- 
sisted of 39 individual samples, was between 40 and 65 per cent with an over-all 
average of 50 per cent, 
A preliminary experiment for the purpose of testing the method for its ability 
to isolate hypertensin from the circulating blood of dogs is shown in Table II. 
The samples that were drawn from the dogs of this group prior to constriction 
of their renal arteries had pressor activity equivalent to 0.02  to 0.05 units of 
hypertensin per liter of blood. After removal of the right kidney and marked 
TABLE  I 
Recovery of Hypertensin Added to Blood 
Sample No. 
17 A 
17 B 
17 C 
17 D 
17 E 
17 F 
17G 
17H 
Hypertensin added 
~its 
o 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
o 
Hypertensin found 
0.02 
0.13 
0.13 
0.13 
0.12 
0.12 
0.14 
0.01 
Recovery of hypertensin 
~n/#s  per ¢¢n# 
0.11  55 
0.11  55 
0.11  55 
0.10  50 
0.10  5O 
0.12  60 
constriction of the left renal artery by a Goldblatt clamp (4), hypertension and 
nitrogen retention developed in all animals. Samples of blood were drawn 48 
and 72 hours after application of the clamps. The concentrations of hyperten- 
sin found in 10 dogs ranged between 0.10 and 1.6 units per liter of blood. All 
3nimals surviving  72  hours  were  sacrificed.  The presence  of  the  malignant 
phase of experimental renal hypertensin was confirmed either by the occurrence 
of multiple hemorrhages in the gastrointestinal tract and other organs or by 
the microscopic observation of necrotizing arteriolitis. 
The pressor activity of 8 final extracts from dogs with acute hypertension 
was tested for its susceptibility to destruction by trypsin. In all cases the pres- 
sot activity of the extracts was completely destroyed. The control tubes which 
contained the inactivated trypsin were strongly pressor. 
15 samples of blood from 9 dogs which had been bilaterally nephrectomized 
for 48 to 72 hours were processed and tested for the presence of pressor activity. 
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amounts which were insufficient to permit identification. The maximum con- 
centration of pressor activity was equivalent to 0.016 units of hypertensin per 
liter of blood. The contour of the pressor response obtained in the rat was in- 
definite and not comparable to that obtained by the injection of similar amounts 
of hypertensin. 
An additional experiment designed to estimate the degree of specificity of 
the method for hypertensin was performed. Representative pressor materials 
were added to separate duplicate samples drawn from a  pool of normal dog 
blood. The amounts added were in each case sufficient to yield a minimum of 
20  easily significant pressor doses in the rat.  The following substances were 
TABLE  II 
Assay of Hypertensin from the Blood of Dogs before and after Constriction of the Renal Artery 
with Development of Malignant Hypertension 
Before constric-  48 hrs. after constriction  72 hrs. after constriction  tion 
Dog No. 
43 
67 
41 
55 
62 
76 
80 
82 
83 
89 
Hypertensin 
found 
unlJs per liter 
0.03 
0.04 
0.02 
0.05 
0.02 
No sample 
0.05 
0.02 
0.04 
0.02 
Blood urea 
nitrogen 
rag.  per 100 ml. 
75 
190 
96 
150 
146 
No sample 
104 
93 
86 
119 
Mean 
femoral  [ Hyperten- 
blood  I sin found 
pressure  __ 
~  1:1  U¢I~$  per 
....... ~g  '  liter 
185  0.10 
190  1.2 
165  0.20 
160  0.17 
175  0.12 
185  0.20 
155  0.28 
185  0.24 
165  0.29 
160  0.10 
B• 
~dmm 
~'oge 
m  per  '0~ 
mL 
104 
)ead 
207 
146 
)ead 
218 
159 
153 
141 
150 
Hyper- 
tensin 
found 
units per 
liter 
0.10 
Dead 
0.25 
1.0 
Dead 
1.6 
0.36 
0.28 
1.0 
0.21 
used: 0.1  pressor unit of pitressin, 2.5 rag. of ACTH (Armour and Co.),  1.0 ~g 
of arterenol, 0.1 rag. tyramine hydrochloride, and 1.0 ~g. of epinephrine. In no 
case did these substances add additional significant pressor activity to the final 
extracts. 
DISCUSSION 
The blood samples are drawn as rapidly as possible from the dog into ethanol 
in order to avoid the possible error that could occur due to the production of 
hypertension by the extravascular action of renin on its substrate or by the 
destruction of the hypertensin by hypertensinase. 
The chemical method described represents a  compromise between an effort 
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covery rate as high as 80 per cent can be obtained by eluting the adsorbed 
hypertensin from the alumina column by boiling water; however, in addition 
to the hypertensin, a  depressor  substance  is also recovered  which  interferes 
with the final assay in the rat. 
The pressor  material obtained from dogs with malignant hypertension was 
identified as hypertensin by the following means. The material was completely 
destroyed by trypsin, eliminating all  known pressor  materials with the ex- 
ception  of pitressin  and ACTH. These  two possibilities were excluded by ex- 
amination of the contour of the pressor response obtained as well as by failure 
to recovery  these  substances  by the method used  when reasonable  amounts 
were added to blood  samples. 
There was not sufficient pressor activity in the extracts of blood of normal 
dogs to permit inactivation experiments with trypsin. For this reason, samples 
of blood from bilaterally nephrectomized  dogs were prepared for assay.  The 
lack of pressor activity in these preparations would indicate that the material 
obtained from normal dogs was of renal origin. 
It must be emphasized  that the pressor  activity of the blood  extracts of 
both normal dogs and those with malignant hypertension may have been in- 
creased by the production of hypertensin by circulating  renin released  from 
the animals' kidneys as a  result of withdrawing 250 ml. of blood in 1½  to 4 
minutes. Experiments are now in progress in which attempts are being made 
to obtain blood samples from dogs under more physiological conditions. 
SUMMA.RY 
A method has been  described  for isolation  and assay of hypertensin from 
the blood of dogs. An ethanol filtrate of blood drawn from the femoral artery 
is prepared  and  concentrated by evaporation.  The hypertensin is  extracted 
into  n-butanol  from  which  it  is  adsorbed  into  alumina,  and  subsequently 
eluted with dilute ethanol. The eluate is then evaporated to dryness, dissolved 
in water, and assayed by intravenous injection into rats. 
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